do glp 1 agonists have cardiovascular benefit The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management | Current Risk Reports Discover the Game-Changing Benefits of
Description
In a survey of 436 participants with T1D, 72% of those who drive a vehicle reported having hypoglycemia events while driving, and 4.3% reported having a vehicular accident due to hypoglycemia in the previous 2 years (66)
Retatrutide, a newer triple agonist in development, targets GLP-1, GIP, and glucagon receptors
Available from: European Medicines Agency (EMA) (2023) Suliqua
Time to first intensification with any treatment was calculated using competing risk analysis
[PubMed] [Google Scholar] 31.Ussher JR, Drucker DJ
It can be prescribed off-label to promote weight loss in some cases
